NanoViricides
NNVC
44 hedge funds and large institutions have $3.38M invested in NanoViricides in 2016 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
7% more funds holding
Funds holding: 41 → 44 (+3)
0.02% more ownership
Funds ownership: 0.28% → 0.3% (+0.02%)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
39% less capital invested
Capital invested by funds: $5.54M → $3.38M (-$2.16M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Cowen Inc
New York
|
+$498K |
| 2 |
Fayez Sarofim & Co
Houston,
Texas
|
+$38.1K |
| 3 |
Renaissance Technologies
New York
|
+$35.1K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$19.9K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$14.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$266K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$33.3K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$21K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$14.8K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$12K |
NNVC Hedge Fund Activity: Q4 2016 in Review
44 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q4 2016, worth a combined $3.38M — down 39% from $5.54M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new NNVC positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Cowen Inc, opening a new position worth an estimated $498K. The largest seller was Vanguard Group, cutting an estimated $266K.
- 44 institutional investors held NanoViricides (NNVC) as of Q4 2016, up from 41 in Q3 2016.
- Funds reported $3.38M of NanoViricides stock for Q4 2016, down 39% quarter-over-quarter.
- 6 funds opened new NanoViricides positions in Q4 2016 and 3 closed out, a net change of +3 holders.
- The largest NanoViricides buyer in Q4 2016 was Cowen Inc, an estimated $498K added.
- The largest NanoViricides seller in Q4 2016 was Vanguard Group, an estimated $266K sold.
Based on aggregated 13F filings for Q4 2016.